Lung cancer cells (LCC)

Lung cancer cells are malignant cells arising from the epithelial lining of the respiratory tract, characterized by genomic instability and dysregulated signaling pathways (National Cancer Institute, 2023). These cells are broadly classified into non-small cell lung cancer (NSCLC), which accounts for approximately 85% of cases, and small cell lung cancer (SCLC), known for its aggressive nature and rapid doubling time (American Cancer Society, 2024). While "lung cancer cells" is a cellular designation rather than a single molecular target, these cells harbor specific alterations such as EGFR mutations, ALK rearrangements, and KRAS mutations that serve as focal points for targeted therapies (Nature Reviews Disease Primers, 2021). Treatment regimens often involve a combination of platinum-based chemotherapy, which induces DNA damage, and immunotherapy, such as PD-1/PD-L1 inhibitors that re-engage the immune system to recognize and destroy the malignant cells (The Lancet, 2022). The therapeutic landscape is continuously evolving to address the high degree of intratumoral heterogeneity and the inevitable emergence of resistance mechanisms (Journal of Thoracic Oncology, 2023). Precision medicine has shifted the focus from broad cytotoxic approaches to identifying specific molecular drivers within these cells to improve patient outcomes (New England Journal of Medicine, 2023). Despite advancements, lung cancer cells often develop secondary mutations or bypass pathways, necessitating the development of next-generation inhibitors and combination strategies (Clinical Cancer Research, 2022). Monitoring these cells through liquid biopsies and imaging is essential for assessing treatment efficacy and detecting early signs of progression (Nature Medicine, 2023).

Other names

Pulmonary carcinoma cellsMalignant lung neoplasm cellsLung tumor cells

Drugs targeting lung cancer cells act by inhibiting oncogenic drivers (e.g., EGFR, ALK), blocking immune checkpoints (e.g., PD-1/PD-L1), or inducing direct DNA damage and apoptosis through cytotoxic mechanisms.